DUTCH BROS INC-CLASS A (BROS)

US26701L1008 - Common Stock

52.96  -1.1 (-2.03%)

After market: 52.97 +0.01 (+0.02%)

Fundamental Rating

4

Overall BROS gets a fundamental rating of 4 out of 10. We evaluated BROS against 133 industry peers in the Hotels, Restaurants & Leisure industry. BROS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BROS shows excellent growth, but is valued quite expensive already.



3

1. Profitability

1.1 Basic Checks

In the past year BROS was profitable.
BROS had a positive operating cash flow in the past year.
In multiple years BROS reported negative net income over the last 5 years.
Each year in the past 5 years BROS had a positive operating cash flow.

1.2 Ratios

BROS has a Return On Assets of 1.24%. This is comparable to the rest of the industry: BROS outperforms 44.36% of its industry peers.
The Return On Equity of BROS (5.78%) is better than 61.65% of its industry peers.
The Return On Invested Capital of BROS (2.67%) is worse than 66.17% of its industry peers.
Industry RankSector Rank
ROA 1.24%
ROE 5.78%
ROIC 2.67%
ROA(3y)-0.87%
ROA(5y)2.85%
ROE(3y)-5.56%
ROE(5y)3.94%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of BROS (2.54%) is comparable to the rest of the industry.
BROS has a Operating Margin of 8.58%. This is comparable to the rest of the industry: BROS outperforms 49.62% of its industry peers.
BROS's Operating Margin has improved in the last couple of years.
The Gross Margin of BROS (28.65%) is worse than 79.70% of its industry peers.
In the last couple of years the Gross Margin of BROS has declined.
Industry RankSector Rank
OM 8.58%
PM (TTM) 2.54%
GM 28.65%
OM growth 3Y16.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

BROS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BROS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BROS has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.29 indicates that BROS is not in any danger for bankruptcy at the moment.
BROS's Altman-Z score of 3.29 is fine compared to the rest of the industry. BROS outperforms 78.20% of its industry peers.
BROS has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.13, BROS is in the better half of the industry, outperforming 60.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Altman-Z 3.29
ROIC/WACC0.3
WACC8.9%

2.3 Liquidity

BROS has a Current Ratio of 1.90. This is a normal value and indicates that BROS is financially healthy and should not expect problems in meeting its short term obligations.
BROS has a Current ratio of 1.90. This is amongst the best in the industry. BROS outperforms 83.46% of its industry peers.
A Quick Ratio of 1.68 indicates that BROS should not have too much problems paying its short term obligations.
BROS has a better Quick ratio (1.68) than 81.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.68

8

3. Growth

3.1 Past

BROS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.00%, which is quite impressive.
The Revenue has grown by 30.53% in the past year. This is a very strong growth!
The Revenue has been growing by 43.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y43.42%
Revenue growth 5YN/A
Sales Q2Q%27.87%

3.2 Future

Based on estimates for the next years, BROS will show a very strong growth in Earnings Per Share. The EPS will grow by 32.90% on average per year.
The Revenue is expected to grow by 21.88% on average over the next years. This is a very strong growth
EPS Next Y48.34%
EPS Next 2Y35.55%
EPS Next 3Y32.69%
EPS Next 5Y32.9%
Revenue Next Year30.34%
Revenue Next 2Y25.77%
Revenue Next 3Y24.17%
Revenue Next 5Y21.88%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

BROS is valuated quite expensively with a Price/Earnings ratio of 110.33.
BROS's Price/Earnings ratio is a bit more expensive when compared to the industry. BROS is more expensive than 66.17% of the companies in the same industry.
BROS is valuated expensively when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 92.98, the valuation of BROS can be described as expensive.
BROS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BROS is more expensive than 65.41% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BROS to the average of the S&P500 Index (23.78), we can say BROS is valued expensively.
Industry RankSector Rank
PE 110.33
Fwd PE 92.98

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BROS is valued expensively inside the industry as 80.45% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 44.9

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BROS's earnings are expected to grow with 32.69% in the coming years.
PEG (NY)2.28
PEG (5Y)N/A
EPS Next 2Y35.55%
EPS Next 3Y32.69%

0

5. Dividend

5.1 Amount

BROS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DUTCH BROS INC-CLASS A

NYSE:BROS (12/23/2024, 8:04:01 PM)

After market: 52.97 +0.01 (+0.02%)

52.96

-1.1 (-2.03%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners82.4%
Inst Owner Change2.98%
Ins Owners2.41%
Ins Owner Change-48.58%
Market Cap8.17B
Analysts85.26
Price Target51.43 (-2.89%)
Short Float %6.46%
Short Ratio2.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.52%
Min EPS beat(2)31.52%
Max EPS beat(2)45.53%
EPS beat(4)4
Avg EPS beat(4)153.54%
Min EPS beat(4)31.52%
Max EPS beat(4)427.41%
EPS beat(8)7
Avg EPS beat(8)106.12%
EPS beat(12)9
Avg EPS beat(12)35.85%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.22%
Min Revenue beat(2)0.46%
Max Revenue beat(2)1.98%
Revenue beat(4)3
Avg Revenue beat(4)1.6%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)5.4%
Revenue beat(8)5
Avg Revenue beat(8)-0.36%
Revenue beat(12)8
Avg Revenue beat(12)0.14%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.76%
PT rev (3m)25.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-46.09%
EPS NY rev (1m)3.96%
EPS NY rev (3m)10.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)2.23%
Valuation
Industry RankSector Rank
PE 110.33
Fwd PE 92.98
P/S 6.85
P/FCF N/A
P/OCF 35.63
P/B 15.61
P/tB 16.4
EV/EBITDA 44.9
EPS(TTM)0.48
EY0.91%
EPS(NY)0.57
Fwd EY1.08%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)1.49
OCFY2.81%
SpS7.73
BVpS3.39
TBVpS3.23
PEG (NY)2.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 5.78%
ROCE 4.54%
ROIC 2.67%
ROICexc 3.05%
ROICexgc 3.09%
OM 8.58%
PM (TTM) 2.54%
GM 28.65%
FCFM N/A
ROA(3y)-0.87%
ROA(5y)2.85%
ROE(3y)-5.56%
ROE(5y)3.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-21.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y-16.95%
ROICexc growth 5YN/A
OM growth 3Y16.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5YN/A
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Debt/EBITDA 3.13
Cap/Depr 274.85%
Cap/Sales 20.1%
Interest Coverage 2.81
Cash Conversion 120.98%
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.68
Altman-Z 3.29
F-Score6
WACC8.9%
ROIC/WACC0.3
Cap/Depr(3y)406.7%
Cap/Depr(5y)377.88%
Cap/Sales(3y)24.29%
Cap/Sales(5y)20.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y48.34%
EPS Next 2Y35.55%
EPS Next 3Y32.69%
EPS Next 5Y32.9%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y43.42%
Revenue growth 5YN/A
Sales Q2Q%27.87%
Revenue Next Year30.34%
Revenue Next 2Y25.77%
Revenue Next 3Y24.17%
Revenue Next 5Y21.88%
EBIT growth 1Y104.09%
EBIT growth 3Y67.1%
EBIT growth 5YN/A
EBIT Next Year178.6%
EBIT Next 3Y61.07%
EBIT Next 5Y45.13%
FCF growth 1Y91.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y350.74%
OCF growth 3Y37.73%
OCF growth 5YN/A